Skip to menu Skip to content Skip to footer

Featured

2003

Journal Article

Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis

Pender, Michael P., Csurhes, Peter A., Wolfe, Nigel P., Hooper, Kaye D., Good, Michael F., McCombe, Pamela A. and Greer, Judith M. (2003). Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. Journal of Clinical Neuroscience, 10 (1), 63-66. doi: 10.1016/S0967-5868(02)00270-9

Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis

2002

Journal Article

Prevention of Autoimmune Attack and Disease Progression in Multiple Sclerosis: Current Therapies and Future Prospects

Pender, M. P. and Wolfe, N. P. (2002). Prevention of Autoimmune Attack and Disease Progression in Multiple Sclerosis: Current Therapies and Future Prospects. Internal Medicine Journal, 32 (11), 554-563. doi: 10.1046/j.1445-5994.2002.00269.x

Prevention of Autoimmune Attack and Disease Progression in Multiple Sclerosis: Current Therapies and Future Prospects

2002

Conference Publication

Comparison of NF-kB in immune cells of multiple sclerosis patients and controls Society for Cytokines, Inflammation and Leukocytes

Yan, J., Inglis, H., Pender, M. P. and Greer, J. M. (2002). Comparison of NF-kB in immune cells of multiple sclerosis patients and controls Society for Cytokines, Inflammation and Leukocytes. 32nd Annual Scientific Meeting of the ASI, Brisbane, Qld, Australia, 8-12 December, 2002.

Comparison of NF-kB in immune cells of multiple sclerosis patients and controls Society for Cytokines, Inflammation and Leukocytes

2002

Conference Publication

Blood T-cell reactivity to gangliosides GM3 and GQ1b is increased in patients with primary progressive multiple sclerosis

Pender, M. P., Csurhes, P. A., Wolfe, N. P., Cameron, K. D., McCombe, P. A., Greer, J. M. and Good, M. F. (2002). Blood T-cell reactivity to gangliosides GM3 and GQ1b is increased in patients with primary progressive multiple sclerosis. 127th Annual Meeting of the American Neurological Association, New York City, NY, USA, October 12-16 2002. NEW YORK: WILEY-LISS.

Blood T-cell reactivity to gangliosides GM3 and GQ1b is increased in patients with primary progressive multiple sclerosis

2002

Conference Publication

Comparison of regulatory cell populations in patients with multiple sclerosis and controls

Yan, J., Rist, M. J., Dodson, M. J., Pender, M. P. and Greer, J. M. (2002). Comparison of regulatory cell populations in patients with multiple sclerosis and controls. Progress in MS Research, Sydney, 9-11 Oct, 2002.

Comparison of regulatory cell populations in patients with multiple sclerosis and controls

2002

Conference Publication

T cell responses to gangliosides in patients with inflammatory neuropathy

McCombe, P. A., Sullivan, A. A., Alizart, M. A., Csurhes, P. A., Greer, J. M. and Pender, M. P. (2002). T cell responses to gangliosides in patients with inflammatory neuropathy. Xth International Congress on Neuromuscular Diseases, Vancouver, Canada, 07-12 Jul 2002. Amsterda, The Netherlands: Elseiver. doi: 10.1016/S0022-510X(02)80069-7

T cell responses to gangliosides in patients with inflammatory neuropathy

2001

Journal Article

Apoptosis of Inflammatory Cells in Immune Control of the Nervous System: Role of Glia

Pender, Michael P. and Rist, Michael J. (2001). Apoptosis of Inflammatory Cells in Immune Control of the Nervous System: Role of Glia. Glia, 36 (2), 137-144. doi: 10.1002/glia.1103

Apoptosis of Inflammatory Cells in Immune Control of the Nervous System: Role of Glia

2001

Journal Article

The Use of Interferon Beta at the Time of Initial Diagnosis of Multiple Sclerosis

Pender, Michael P. (2001). The Use of Interferon Beta at the Time of Initial Diagnosis of Multiple Sclerosis. Journal of Clinical Neuroscience, 8 (4), 381-382. doi: 10.1054/jocn.2001.0913

The Use of Interferon Beta at the Time of Initial Diagnosis of Multiple Sclerosis

2001

Journal Article

Cyclosporin A Treatment Modulates Cytokine mRNA Expression by Inflammatory Cells Extracted from the Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis Induced by Inoculation with Myelin Basic Protein

Harness, Jackie, Pender, Michael P. and McCombe, Pamela A. (2001). Cyclosporin A Treatment Modulates Cytokine mRNA Expression by Inflammatory Cells Extracted from the Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis Induced by Inoculation with Myelin Basic Protein. Journal of the Neurological Sciences, 187 (1-2), 7-16. doi: 10.1016/S0022-510X(01)00505-6

Cyclosporin A Treatment Modulates Cytokine mRNA Expression by Inflammatory Cells Extracted from the Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis Induced by Inoculation with Myelin Basic Protein

2001

Journal Article

Use of traditional and complementary medical care by patients with Multiple Sclerosis in South-East Queensland

Hooper, Kaye D., Pender, Michael P., Webb, Penny M. and McCombe, Pam A. (2001). Use of traditional and complementary medical care by patients with Multiple Sclerosis in South-East Queensland. International Journal of MS Care, 3 (1), 13-28. doi: 10.7224/1537-2073-3.1.13

Use of traditional and complementary medical care by patients with Multiple Sclerosis in South-East Queensland

2001

Journal Article

Rapid entry and downregulation of T Cells in the central nervous system During the reinduction of experimental autoimmune encephalomyelitis

Gordon, F. L., Nguyen, K. B., White, C. A. and Pender, M. P. (2001). Rapid entry and downregulation of T Cells in the central nervous system During the reinduction of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 112 (1-2), 15-27. doi: 10.1016/S0165-5728(00)00341-6

Rapid entry and downregulation of T Cells in the central nervous system During the reinduction of experimental autoimmune encephalomyelitis

2001

Edited Outputs

International Journal of MS Care

International Journal of MS Care. (2001). 3 (1)

International Journal of MS Care

Featured

2000

Journal Article

A Neuropathological Analysis Of Experimental Autoimmune Encephalomyelitis With Predominant Brain Stem And Cerebellar Involvement And Differences Between Active And Passive Induction

Muller, Diane M., Pender, Michael P. and Greer, Judith M. (2000). A Neuropathological Analysis Of Experimental Autoimmune Encephalomyelitis With Predominant Brain Stem And Cerebellar Involvement And Differences Between Active And Passive Induction. Acta Neuropathologica, 100 (2), 174-182. doi: 10.1007/s004019900163

A Neuropathological Analysis Of Experimental Autoimmune Encephalomyelitis With Predominant Brain Stem And Cerebellar Involvement And Differences Between Active And Passive Induction

2000

Journal Article

Multiple Sclerosis

Pender, M. P. (2000). Multiple Sclerosis. Medical Journal of Australia, 172 (11), 556-562. doi: 10.5694/j.1326-5377.2000.tb124107.x

Multiple Sclerosis

2000

Journal Article

B Cell apoptosis in the central nervous system in experimental autoimmune Encephalomyelitis: Roles of B Cell CD95, CD95L and Bcl-2 expression

White, Catherine A., Nguyen, Kim B. and Pender, Michael P. (2000). B Cell apoptosis in the central nervous system in experimental autoimmune Encephalomyelitis: Roles of B Cell CD95, CD95L and Bcl-2 expression. Journal of Autoimmunity, 14 (3), 195-204. doi: 10.1006/jaut.2000.0363

B Cell apoptosis in the central nervous system in experimental autoimmune Encephalomyelitis: Roles of B Cell CD95, CD95L and Bcl-2 expression

2000

Journal Article

Reply

Tayyebeh Sadatipour, B., Greer, Judith M. and Pender, Michael P. (2000). Reply. Annals of Neurology, 47 (5), 685-685. doi: 10.1002/1531-8249(200005)47:53.0.co;2-k

Reply

2000

Journal Article

Reply to letter by Giovanni et. al.

Sadatipour, B. T., Greer, J. M. and Pender, M. P. (2000). Reply to letter by Giovanni et. al.. Annals of Neurology, 47 (5), 685-685.

Reply to letter by Giovanni et. al.

2000

Journal Article

Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis - Reply

Sadatipour, B.T., Greer, J.M. and Pender, M.P. (2000). Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis - Reply. Annals of Neurology, 47 (5), 685-685.

Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis - Reply

2000

Journal Article

Autoimmune Hypothyroidism Associated with Interferon beta-1b Treatment in Two Patients with Multiple Sclerosis

McDonald, N. D. and Pender, M. P. (2000). Autoimmune Hypothyroidism Associated with Interferon beta-1b Treatment in Two Patients with Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 30 (2), 278-279. doi: 10.1111/j.1445-5994.2000.tb00823.x

Autoimmune Hypothyroidism Associated with Interferon beta-1b Treatment in Two Patients with Multiple Sclerosis

2000

Conference Publication

Increased circulating anti-myelin antibodies in multiple sclerosis

Pender, M. P. and Greer, J. M. (2000). Increased circulating anti-myelin antibodies in multiple sclerosis. ANN Meeting, xx, xx. Leith Walkedinburgh, Scotland: Churchill Livingstone. doi: 10.1054/jocn.2000.0668

Increased circulating anti-myelin antibodies in multiple sclerosis